Davis Robert M 4
4 · Merck & Co., Inc. · Filed May 2, 2024
Insider Transaction Report
Form 4
Davis Robert M
DirectorChairman, CEO & President
Transactions
- Award
Stock Option (Right to Buy)
2024-04-30+181,641→ 181,641 totalExercise: $129.22From: 2025-04-30Exp: 2034-04-29→ Common Stock (181,641 underlying)
Holdings
- 348,326.757
Common Stock
Footnotes (1)
- [F1]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.